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The Tlo Proteins Are Stoichiometric Components of Candida albicans
Mediator Anchored via the Med3 Subunit
Anda Zhang,a Kostadin O. Petrov,a Emily R. Hyun,a Zhongle Liu,a Scott A. Gerber,b and Lawrence C. Myersa
Department of Biochemistry, Dartmouth Medical School, Hanover, New Hampshire, USA,a and Department of Genetics and Norris Cotton Cancer Center, Dartmouth
Medical School, Lebanon, New Hampshire, USAb
The amplification of the TLO (for telomere-associated) genes in Candida albicans, compared to its less pathogenic, close relative
Candida dubliniensis, suggests a role in virulence. Little, however, is known about the function of the Tlo proteins. We have pu-
rified the Mediator coactivator complex from C. albicans (caMediator) and found that Tlo proteins are a stoichiometric compo-
nent of caMediator. Manymembers of the Tlo family are expressed, and each is a unique member of caMediator. Protein expres-
sion analysis of individual Tlo proteins, as well as the purification of tagged Tlo proteins, demonstrate that there is a large free
population of Tlo proteins in addition to theMediator-associated population. Coexpression and copurification of Tlo12 and
caMed3 in Escherichia coli established a direct physical interaction between the two proteins. We have also made a C. albicans
med3/ strain and purified an intact Mediator from this strain. The analysis of the composition of themed3Mediator shows
that it lacks a Tlo subunit. RegardingMediator function, themed3/ strain serves as a substitute for the difficult-to-make
tlo/ C. albicans strain. A potential role of the TLO andMED3 genes in virulence is supported by the inability of themed3/
strain to form normal germ tubes. This study of caMediator structure provides initial clues to the mechanism of action of the Tlo
genes and a platform for further mechanistic studies of caMediator’s involvement in gene regulatory patterns that underlie
pathogenesis.
Candida species are opportunistic pathogens that mainly existin harmony with the human host as part of the commensal
flora and cause infection only when host deficiencies permit.Can-
dida albicans and Candida dubliniensis are two highly related
pathogenic yeast species. C. albicans, however, has been shown to
be more pathogenic in a wide range of infection models and is far
more prevalent in human infection (28). In epidemiological stud-
ies, C. albicans has been found to be the most common cause of
superficial and systemic infections. The comparison of the ge-
nomes of the two species has revealed that they are very similar,
although there are some significant differences (20). Determina-
tion of the particular molecular pathways affected by these
genomic differences and revealing their mechanism of action will
lead to a better understanding of whyC. albicans has evolved to be
a successful pathogen. The majority of the genomic differences
observed between theC. albicans andC. dubliniensis species can be
accounted for by the expansion of gene families inC. albicans (20).
The greatest difference in gene family size between the two species
is theTLO family, which is comprised of 14 genes inC. albicansbut
only two genes in C. dubliniensis.
TheTLO genes inC. albicans (caTLO) are a family of 14 closely
related paralogs (average nucleotide identity, 96.5%) primarily
located subtelomerically. The two TLO paralogs in C. dubliniensis
are relatively well diverged (nucleotide identity, 74.9%), while
Candida tropicalis only has one (20). The TLO genes can be sub-
divided into three clades (, , and ), based largely on the pres-
ence of indels and the alternative splicing of a subset of sequences
that contain an intron () (M. Anderson and J. Berman, unpub-
lished data). Due to the large number of TLO genes, a C. albicans
tlo/ strain is challenging to construct. Hence, the first insight
into TLO gene function came from null mutants for C. dublinien-
sis TLO1 that showed a major reduction in hypha formation in
response to serum (20). The caTLO genes TLO11 and TLO12
appear to have similar functionality in that they are both able to
complement the phenotype of the C. dubliniensis tlo1 null (20). A
clue to a potentialmechanistic role for theTLO genes was revealed
using a bioinformatics approach that suggested that the TLO
genes were a distantly related ortholog of a subunit of the S. cerevi-
siaeMediator complex (6).
Mediator is a conserved interface between gene-specific regu-
latory proteins and the general transcription apparatus of eu-
karyotes. Transcription in purified and extract-based systems, in
vivo studies, and cell-based assays have revealed Mediator to be a
critical functional target for a wide variety of activators (9). The
analysis of purifiedMediator has demonstrated that the core of the
Saccharomyces cerevisiae complex is composed of 21 polypeptides
(14, 31). Biochemical (3) and structural (8) studies have allowed
the assignment of subunits to structurally distinct modules of the
Mediator complex, referred to as tail, middle, and head. The Cdk8
module is a separate subset of proteins that is variably associated
with the core Mediator subunits (5, 36). Parallel biochemical and
genetic experiments have demonstrated that certain Mediator
subunits are critical for the activation of specific sets of genes (31,
45). Transcriptional profiling in vivo shows that other Mediator
subunits are essential for the transcription of virtually all genes in
S. cerevisiae (18), suggesting that the complex was also a general
transcription factor. Additional studies of S. cerevisiae have also
pointed to a role for some Mediator subunits in transcriptional
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repression and silencing that likely involves chromatin (19, 21, 38,
39, 49, 50).
A majority of S. cerevisiae Mediator subunits have clear or-
thologs in virtually all eukaryotes (6, 10, 37). The approximately
half of S. cerevisiaeMediator subunits that are encoded by essential
genes have amino acid identity levels as high as 20 to 30% with
their mammalian counterparts. Med2 andMed3 are two subunits
of S. cerevisiaeMediator that have no obvious orthologs in meta-
zoans and have clear orthologs in only a small group of closely
related fungi. S. cerevisiae Med2 (scMed2) and scMed3 are en-
coded by nonessential genes, occupy the extreme end of the tail
module, and stabilize each other’s presence in Mediator (25, 30).
BLAST searches find clear orthologs of scMed2 and scMed3 in
closely related fungi such as Kluyveromyces, but none in most
other fungi, including C. albicans and C. dubliniensis. Using short
motifs, however, a bioinformatics approach predicted the Tlo
proteins to be the C. albicans orthologs of scMed2 (6). This pre-
diction raised the question of whether one or more of the C. albi-
cansTloproteinswere subunitsofC.albicansMediator (caMediator).
If Tlo proteins are subunits of the complex, it also begged the
question of whether they play a structural and functional role in
the complex that lends insight into this unusually large set of para-
logs and their potential roles in virulence. Our characterization of
the composition of C. albicans Mediator has shown that several
Tlo proteins are members of Mediator. Our biochemical charac-
terization of the interaction between the Tlo proteins and the
caMed3 subunit of Mediator, as well as the analysis of amed3 null
mutant, suggests that the Tlo proteins participate in processes that
affect virulence through their membership in the Mediator com-
plex.
MATERIALS AND METHODS
Tagging plasmids. The plasmid pURA-GSCP (43) was used for C-termi-
nal tagging with amodified TAP tag, and the plasmids pFA-HA-HIS1 and
pFA-HA-ARG4 (24) were used for C-terminal tagging with a hemagglu-
tinin (HA) epitope tag as previously described. To construct the tagging
vectors pFA-FLAG-HIS1 and pFA-FLAG-ARG4, the 3FLAG epitope
was amplified from the strain yLM40 (1) using the primer pair LM010/
LM009. This product was cleaved with KpnI and AscI and ligated into
KpnI/AscI-cut pFA-HA-HIS1 and pFA-HA-ARG4 vectors (24), and the
constructs were verified by sequencing. To construct the pFA-6His-
FLAG-HIS1 vector for adding a dual 6-histidine (6His)/3Flag tag to the
C termini of proteins, the primer pair SRP017/SRP016 was used to am-
plify a PCR product from pFA-HA-FLAG that added a 6His tag in frame
with the 3Flag. This PCR product was cleaved with AatII and KpnI and
ligated into the AatII/KpnI-cut vector, and the construct was verified by
sequencing. Tomake versions of pFA-HA and pFA-6His-FLAG that have
nourseothricin (ClonNAT) resistance rather than histidine prototrophy
as the selectable marker, we amplified the ClonNAT resistance gene from
the SAT1marker in pSFS2 (35) using the primer pair SRP011/SRP012, cut
this product with AscI and PmeI, and ligated it into AscI/PmeI-cut pFA-
HA-HIS1 and pFA-6His-FLAG-HIS1. The sequences of all primers de-
scribed are listed in Table S2 in the supplemental material.
Strains. The genotypes of all strains used in this work are listed in
Table S1 in the supplemental material. In this paper, the caMediator sub-
units are assigned to specific open reading frames (ORFs) in the C. albi-
cans database as shown in Fig. 2, and the TLO designations are assigned to
specific ORFs in the C. albicans database as previously described (20). All
tagged strains were made by transformation of C. albicans strains using a
PCR product with at least 70 bp of homology, derived from the primer, to
each region targeted. The appropriate targeting in positive colonies was
monitored by PCR of the flanking regions (primer sequences are available
upon request) and Western blotting of the tagged protein in whole-cell
extracts. Since the DNA sequence of the TLO genes is nearly identical in
both the ORF and 3=-untranslated region (UTR), all tagged TLO con-
structs were further verified by the complete sequencing of the ORF to
confirm that the correct gene was tagged. To construct the Med8-6His-
Flag-tagged strain (yLM112) forMediator purification, the 6His-Flag cas-
sette was amplified from pFA-6His-FLAG-SAT1 using the primer pair
LM025/LM014 and used to transform KPC1 (BWP17) (47). A second
strain for Mediator purification (yLM83), in which both copies of Med15
were Flag tagged, was constructed by amplifying the Flag cassette from
pFA-FLAG-HIS1 and pFA-FLAG-ARG4 with the primer pair LM024/
LM012 and sequentially transforming KPC1 (BWP17). To construct
KPC3, inwhich a single copy ofMED8 is tagged at the C terminuswith the
GSCP tag, the GSCP tagging cassette was amplified from plasmid pURA-
GSCP with the primer pair KPP004/KPP005 and transformed into KPC1
(BWP17). To construct the HA-tagged Tlo and Mediator strains, the fol-
lowing primer pairs were used to amplify the HA-HIS1 cassette from
pFA-HA-HIS1 and transform KPC3: KPC6 TLO12-HA (KPP035/
KPP037), KPC9 TLO3-HA (KPP035/KPP039), KPC11 TLO34-HA
(KPP035/KPP041), KPC22 TLO1-HA (KPP035/KPP055), KPC23
TLO10-HA (KPP035/KPP057), KPC28MED19-HA (KPP074/KPP075),
and KPC29MED16-HA (KPP078/KPP079). Tomake the strains in which
TLO12 was Flag tagged and either one or two copies ofMED3 were HA
tagged, the primer pair KPP035/KPP37 was first used to amplify the
FLAG-HIS1 cassette from pFA-FLAG-HIS1 and transform KPC1
(BWP17). To HA tag the first copy of MED3 in the TLO12-Flag strain,
the primer pair LM017/LM018was used to amplify theHA-ARG4 cassette
from pFA-HA-ARG4 and transform the TLO12-Flag strain to obtain
yLM107. ToHA tag the second copy ofMED3 in yLM107, the primer pair
LM017/LM018 was used to amplify theHA-SAT1 cassette from pFA-HA-
SAT1 and transform yLM107 to obtain yLM109. The heterozygous and
homozygous med3 null strains were made using a previously described
method (34) and the gene-specific primersMED3-P1,MED3-P3,MED3-
P4, andMED3-P6. The first copy ofMED3 in yLM92, aMTLa/a derivative
of SN152 (34) selected on sorbose, was replaced by HIS1 to generate the
med3 heterozygous null strain (yLM93). The second copy of MED3 in
yLM93 was replaced by LEU2 to generate the homozygous med3 null
strain yLM96. A 6His-Flag tag was placed on the C terminus of Med8 for
the purification ofMediator from a homozygousmed3 null strain. yLM96
was transformed with a PCR product containing the 6His-Flag cassette,
amplified from pFA-6His-FLAG-SAT1 using the primer pair LM025/
LM014, to generate yLM114. For the phenotypic analysis of themed3 null
strain, a MED3 complemented strain (AZC53-3) and complementation
control strain (AZC54-1) were constructed. Briefly, the ORF of MED3
and about 400 bp of its upstream region were amplified from C. albicans
genomic DNA by the primer pair AZP139/AZP140 and digested by KpnI
and BamHI. In addition, a 400-bp region immediately 3= to the end of the
MED3 ORF was amplified from genomic DNA by primer pair AZP141/
AZP142 and digested by NotI and ApaI. Plasmid pAZE030 was generated
by inserting these two DNA fragments sequentially into plasmid pSN69
(34). The plasmid for generatingmed3 null complemented control strain
pAZE029 was constructed in a similar way, except that only the400-bp
region upstream of MED3 was amplified, using primer pair AZP139/
AZP144, and inserted into pSN69. The complemented and control strains
were constructed by transforming yLM96 with KpnI-linearized pAZE030
and pAZE029. Positive colonies were tested by PCR for correct integra-
tion. Five complemented strains confirmed by PCR tests were carried out
for further phenotypic analysis, and all of them showed phenotypes sim-
ilar to those ofMED3 heterozygotes. Two complemented control strains
had phenotypes that were similar to each other and to amed3 nullmutant.
Purification of native proteins from C. albicans.Mediator was puri-
fied from C. albicans strains containing Mediator subunits tagged at their
C terminus with either a Flag tag or a combined 6His-Flag tag at their
native loci. The procedures were identical for each strain, except that the
final IMAC (immobilized metal affinity chromatography) purification
step was skipped for the strains lacking a 6His tag. All chromatographic
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steps were at 4°C unless otherwise stated. Tagged C. albicans strains were
grown at 30°C to mid-log phase in yeast extract-peptone-dextrose (YPD)
plus uridine, harvested by centrifugation, andwashed oncewith cold dou-
ble-distilled water, followed by one wash with 1 lysis buffer (180 mM
Tris-acetate [OAc] [pH 7.8], 400mMpotassium acetate [KOAc], 1.2mM
EDTA, 12% glycerol) with 1mMdithiothreitol (DTT) and 1 proteinase
inhibitor cocktail (PIC) (32). The cell pellet was extruded through a sy-
ringe and flash frozen in liquid N2. Cells (25 g) were lysed under liquid
N2 by manual grinding with a mortar and pestle. The ground, frozen
powder was allowed to slowly thaw and was resuspended in 2 volumes of
1.5 lysis buffer with 0.5 mM DTT and 1 PIC. The resuspended cells
were sonicated (4 cycles [45 s on, 45 s off] at 20% power with a Sonic
Dismembrator Model 500 [Fisher Scientific]) on ice. MgOAc was added
to the sonicated lysate to a final concentration of 2.5 mM, followed by the
addition of 200Uof benzonase (EMD).After stirring for 15min, the lysate
was centrifuged for 2 h at 36,000 rpm in aTi45 rotor. The lysis supernatant
was adjusted to 150mMKOAcwith buffer F-0 (25mMHEPES-KOH[pH
7.6], 0.01% NP-40, 10% glycerol, and the concentration of KOAc in mM
after the dash [e.g., F-0 indicates 0 mM KOAc]) with 0.5 mM DTT and
PIC. The adjusted lysate was applied at 1 column volume (CV) per h to
heparin Sepharose (GEHealthcare) equilibrated in buffer F-150 (with 0.5
mMDTT and PIC) using1ml of resin per 10mg of total protein loaded.
The application of the lysate was followed by 1 CV of F-150 (with 0.5 mM
DTT and PIC), and the unbound protein was saved for further analysis
(see below). The column was washed with 2 CV of F-260 (with 0.5 mM
DTT and PIC), and the intact Mediator was eluted with 2 CV of F-500
(with 0.5 mM DTT and PIC). Mediator-containing fractions, judged by
Western blotting with an anti-Flag antibody, were pooled, incubated with
200 l of M2 Flag agarose (Sigma), and equilibrated in F-300 (with 0.25
mM DTT and PIC) for 4 h with rotation. The amount of heparin F-500
eluate loaded was adjusted according to the Flag signal. The unbound
protein was drained from the column, and the resin was washed twice
with 10ml F-300 (with 0.25mMDTT and 1 PIC) followed by one wash
with 10ml F-300 (with 0.25mMDTT, PIC, and 1mMMgOAc). The resin
was resuspended in 500 l F-300 (with 0.25 mM DTT, PIC, 1 mM
MgOAc, and 100Ubenzonase) and incubated at room temperature for 30
min. Two 10-ml F-300 (with 2.5 mM -mercaptoethanol [-ME] and
PIC) washes were followed by five 250-l elutions with F-300 (with 2.5
mM -ME, PIC, and 50 g/ml 3Flag peptide). Mediator containing
Flag elution fractions were pooled, incubated with 125 l of TALON
(Clontech), and equilibrated with F-300 (with 2.5 mM -ME plus PIC)
for 2 h with rotation. After draining the unbound protein and five 2-ml
F-300 (with 2.5 mM -me and PIC) washes, Mediator was eluted with
F-300 (with 2.5 mM -ME, PIC, and 100mM imidazole). To purify Flag-
tagged Tlo12 from the heparin flowthrough, the unbound protein hep-
arin fractions were adjusted to 300 mMKOAc and the Flag-agarose puri-
fication was run as described above.
Mass spectrometry. Talon elutions from parallel preparations from
an untagged and a Med8-6His-Flag-tagged strain were trichloroacetic
acid (TCA) precipitated, and the precipitates were washed twice with
high-performance liquid chromatography-mass spectrometry (HPLC-
MS)-grade acetone (Burdick and Jackson), dried by vacuum centrifuga-
tion, and treated with 20 l of a 5-ng/l trypsin solution (MS sequencing
grade; Promega) overnight at 37°C. The resulting digest was desalted us-
ing an OASIS HLB solid-phase extraction plate (Waters) and analyzed by
microcapillary LC-Orbitrap-MS/MS essentially as described previously
(22, 23) using a long (90-min) analytical gradient. Tandem mass spectra
were data searched using the SEQUEST algorithm (13) and the UniProt
complete proteome set for C. albicans (www.uniprot.org; accessed on 17
February 2010), andpeptide spectralmatcheswere filtered to an estimated
false discovery rate of 1% at the peptide level using the target-decoy
strategy (12) and reported. To determine the identity of individual bands,
the Med8-6His-Flag-tagged sample was subjected to SDS-PAGE in 7.5%
and 12.5% gels and stained with colloidal Coomassie dye. Individual
bands were excised and analyzed by LC-MS/MS at the Proteomics Core
Facility of the Vermont Genetics Network as previously described (40). A
band was assigned to a particular Mediator subunit based on peptides from
that protein being the principal component of that sample versus other
bands. Tables of the rawmass spectroscopy data are available upon request.
Antibodies. Recombinant caMED1 (amino acids 440 to 618) was
fused to glutathione-S-transferase (GST), overexpressed in E. coli Rosetta
2 (Novagen) cells, and subsequently purified using glutathione Sepharose
4B (GE Healthcare) according to the manufacturer’s recommendations.
The pure recombinant protein was supplied as an antigen to Rockland
Immunochemicals Inc. for the immunization of rabbits. For the so-called
pan-Tlo antibody, the peptides ENLQTRLHNSLDEILK and DQNRKQS
NVITSPNNELIQK were coinjected into rabbits for antibody production
(Open Biosystems, Inc.). HA-tagged proteins were detected via Western
blotting with a monoclonal anti-HA antibody (MMS-101R; HA.11; Co-
vance). As a loading control in whole-cell extract Western blot analyses,
the membrane was stripped and reprobed with rat -Tub1 raised against
S. cerevisiae Tub1 (no. ab1616; Abcam, Cambridge, MA). Western blots
were performed using alkaline phosphatase-conjugated secondary anti-
bodies and a fluorescent substrate (ECF; GE Healthcare) that could be
quantified by imaging.
Binding assays.To analyze C-terminal domain (CTD) binding, 10g
purified GST-CTD (15) or GST was bound to 5 l of glutathione Mag-
Beads (Genscript). Unbound proteins were removed by washing the
beads in F-300 buffer containing 0.5 mM DTT. Equimolar amounts of
purified S. cerevisiaeMediator (1) andC. albicansMediator were added to
the beads and incubated for 2 h. The supernatant was saved after incuba-
tion as the flowthrough fraction representing the unbound Mediator.
Bound Mediator complex was eluted by boiling the beads in SDS-PAGE
loading dye. To analyze activation domain binding, 10 g purified GST-
VP16 or GST-VP16456 (17) was bound to 5l of glutathioneMagBeads
(Genscript). Unbound proteins were removed by washing the beads in
F-300 buffer containing 0.5 mMDTT. Equimolar amounts of purified C.
albicans Mediator were added to the beads and incubated for 2 h. The
supernatant after incubation was saved as the flowthrough fraction rep-
resenting the unboundMediator. BoundMediator complexwas eluted by
boiling the beads in SDS-PAGE loading dye.
Purification of the recombinant Tlo12/Med3 cocomplex. To con-
struct a Tlo12/Med3 bicistronic E. coli expression vector with a 6His tag
on the C terminus of Med3, the MED3 gene was first amplified from C.
albicans genomic DNA by PCR using the primer pair EHP001/EHP002.
The PCR product was cleaved with restriction enzymes SalI and NotI and
inserted into the pET21b vector (Novagen). To first isolate TLO12 from
other TLO genes, a TLO12-containing fragment was amplified from C.
albicans genomicDNAusing the primer pair EHP003/EHP004. The prod-
uct was cleaved by XhoI and NotI and inserted into the pBSKS vector
(Stratagene/Agilent). An individual clonewas confirmed to beTLO12 by
DNA sequencing. The primer pair EHP005/EHP006 was used to amplify
the TLO12 ORF from this vector, and the product was cleaved by NheI
and EcoRI and inserted into the pET21b-MED3-6His vector upstream of
the Med3 gene. The two CUG codons in TLO12 and the one in MED3
were replaced with UCG using site-directed mutagenesis (QuikChange
lightningmultisite-directedmutagenesis kit) to create the final bicistronic
expression vector, pET21b-TLO12-MED3-6His, which was confirmed
by sequencing.E. coliBL21(DE3) competent cells (Stratagene)were trans-
formedwith the pET21b-TLO12-MED3-His6 plasmid, and positive col-
onies were inoculated in LBmedium (plus Amp). The cells were grown at
37°C to an optical density at 600 nm (OD600) of 0.5 to 0.6, induced by
adding isopropyl--D-thiogalactopyranoside (IPTG) to a final concentra-
tion of 1 mM, and harvested after 4 h of shaking at 25°C. The harvested
cells were resuspended in IMAC buffer (50 mM sodium phosphate, pH
8.0, 300 mM NaCl) and lysed in a French pressure cell. After centrifuga-
tion, Tlo12 andMed3-6His were found to be in the soluble fraction and
were subjected to purification by IMAC using Talon resin (Clontech)
according to the manufacturer’s protocols. Tlo12 and Med3-6His were
both depleted from the load and recovered in the elution. Ion-exchange
Zhang et al.
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chromatography separated the TLO12/Med3-6His complex from excess
Med3-6His. The Talon elution fractions containing Tlo12 and Med3-
6His were loaded onto a Mono QHR 5/5 column (GE Healthcare) equil-
ibrated in buffer A-100 (25 mM Tris-Cl [pH 7.5], 10 mM -ME, and the
mM amount of NaCl after the dash [e.g., A-100 indicates 100 nMNaCl]),
washed with 5 column volumes of A-100, and eluted with a 20-ml linear
gradient from A-100 to A-600. Fractions containing stoichiometric
amounts of Tlo12 andMed3-6His were eluted at260mMNaCl. These
fractions were analyzed further by size-exclusion chromatography on
Superose 6 (GE Healthcare) equilibrated in 50 mM sodium phosphate
(pH 7.8), 300 mM NaCl, and 10 mM -ME.
Germ tube formation assays. Cultures were allowed to grow over-
night in YPDmedium at 30°C to saturation. They were then reinoculated
into 3ml YPDmedium supplemented with 2.5 mMN-acetylglucosamine
(GlcNAc) (Sigma) at an OD600 of 0.2. After growing at 37°C on a roller
drum for a certain amount of time, cells were harvested and stained with
50 g/ml Blankophor (Valeant Pharmaceuticals) and analyzed using a
DeltaVision Imaging System (Applied Precision) and the light field polar-
ized differential interference contrast (POL DIC) or fluorescence (4=,6-
diamidino-2-phenylindole [DAPI]) channel. Cell morphology was as-
sessed in repeats on multiple days.
RESULTS
Purification and characterization of C. albicans Mediator re-
veals presence of Tlo proteins. To purify the native C. albicans
Mediator, we devised new tagging constructs based on the pFA
series of tagging vectors for C. albicans created by Whiteway and
colleagues (24). Various tagging vectors with the 3Flag (Sigma)
and/or 6His tags and an expanded set of selectable markers were
constructed for use in purification. Our experience purifying S.
cerevisiae Mediator suggested that the 3Flag tag would be an
excellent tag for efficient recovery of large amounts of intact com-
plex. For many S. cerevisiae Mediator subunits, there are clear C.
albicans orthologs with 20% or greater amino acid identity (6).
Among these well-conserved subunits, we found several that were
suitable for tagging and purification. For the work described in
this paper, however, we settled on placing a 6His tag followed by a
3Flag tag on the C terminus of caMed8. Since the M2-Flag
antibody has several cross-reactivities in C. albicans, we included
the 6His tag to clean up any major impurities left after Flag-aga-
rose. For the purification of caMediator, we prepared whole-cell
lysates from taggedC. albicans strains and separated the lysate into
bound and unbound fractions using heparin Sepharose. Intact
Mediator binds heparin and can be eluted with 500 mM KOAc.
This preparatory step served to increase the recovery of the pri-
mary affinity chromatography step and also to separate tagged
Mediator subunits that were not incorporated into the larger
complex away from intact Mediator (see below). Heparin-pro-
cessed whole-cell lysate from an untagged and a Med8-tagged
strainwere further processed in parallel by Flag-agarose andTalon
chromatography, and the elutions were analyzed by silver stain
(Fig. 1A). Comparison of the elutions from the tagged and un-
FIG 1 Composition and functional characterization of C. albicansMediator. (A) Lysates from an untagged and a Med8-6His-Flag-tagged strain were subjected
in parallel to multiple chromatographic separations. The elutions from the IMAC (Talon) step were analyzed by 7.5% (results above the asterisk) and 12.5%
(below the asterisk) SDS-PAGE. The two gels were run on identical samples to ensure adequate resolution in both the high- and low-molecular-mass ranges.
Proteins were revealed by staining with silver. The annotated identity of each band was determined by excising the band from another SDS-PAGE gel run in
parallel and usingmass spectrometry to analyze the protein content of each band. (B) Purified scMediator and caMediator bind to the CTD of RNAPol II. Either
GST or GST-CTD was prebound to magnetic glutathione beads, and a standardized amount of purified scMediator or caMediator was added (Input). The
samples were monitored by Western blotting using the anti-Flag antibody against a Flag tag on scMed18 or caMed15. Percentages represent the percentages of
the total sample at each stage that was loaded onto the gel. The flowthrough (FT) shows that GST-CTD, but not GST, depleted both scMediator and caMediator
from the input. The bound scMediator and caMediator were recovered in the elution (Eltn) from the GST-CTD beads, while no detectable signal was recovered
from the GST beads. (C) Purified caMediator binds to the activation domain of VP16, not an activation-deficient mutant (VP16456). Either GST-VP16 or
GST-VP16456 was prebound to magnetic glutathione beads, and a standardized amount of purified caMediator was added (Input). The samples were
monitored byWestern blotting using the caMed1 antibody and the anti-Flag antibody against a Flag tag on caMed15. The percentages are of the total sample at
each stage that was loaded onto the gel. Bound caMediator was recovered in the elution (Eltn) from the GST-VP16 beads, while little detectable signal was
recovered from the GST-VP16456 beads.
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tagged strains reveals that themajor bands in theMed8-6His-Flag
elution are specific to the tagged sample, although some minor
impurities do survive the tandem affinity chromatography ap-
proach. To determine the composition of the purified complex,
we took twodistinctmass spectrometry approaches. First, weTCA
precipitated the tagged and untagged elution fractions (Fig. 1A)
and subjected them directly to tandemmass-spectroscopic analy-
sis. After subtracting the proteins found in the untagged strain
from those found in the tagged strain, we were basically left with
the composition of caMediator. This analysis showed that all or-
thologs, including the Tlo proteins, predicted by the bioinformat-
ics approach (6) were present in the sample (Fig. 2). Since the Tlo
proteins have very high amino acid sequence identity, it was dif-
ficult to distinguish individual Tlo proteins bymass spectrometry,
although we did find a peptide specific to Tlo12. Aside from the
predicted Mediator subunits, the only other proteins specific to
the tagged sample were the two large subunits of RNA polymerase
II (Pol II). The presence of small amounts of RNA Pol II was not
unexpected, given that Mediator is known to interact with RNA
Pol II through the CTD of the large subunit (31). A second mass
spectrometry approach was used to assign specific bands from
SDS-PAGE to specific subunits.We ran the TCA precipitate of the
tagged sample on SDS-PAGE, excised individual bands, and
subjected them to tandem mass spectrometry analysis. Using
this data, it was relatively straightforward to assign subunits
to individual bands, as shown in Fig. 1A. It is interesting that
the subunits of the Cdk8 module, which do not copurify with
the core scMediator using a similar protocol, are present in the
caMediator complex. The subunits of the Cdk8 module, how-
ever, may be present on a subset of the Mediator complexes
isolated, since the bands stain less intensely than their core
subunit counterparts. This analysis also revealed more unique
Tlo peptides originating from Tlo9 and Tlo2. To verify that
the purified caMediator possessed activities characteristic of
functional, purified S. cerevisiae Mediator, we performed CTD
and activation domain binding assays. In the CTD binding
assay, a GST-CTD fusion protein was added to purified Medi-
ator, and glutathione-Sepharose was used to pull down GST-
CTD-associated proteins. Using this assay, we demonstrated
that an equimolar amount of wild-type (WT) caMediator binds
to a peptide containing CTD repeats of S. cerevisiae RNA Pol II
with equal affinity to scMediator (Fig. 1B). Activation domain
binding assays using a GST-VP16 activation domain fusion
protein and a GST fusion with a VP16 activation domain mu-
tant with attenuated activity (GST-VP16456) showed that,
similarly to its scMediator counterpart (17), caMediator bound
specifically to VP16 (Fig. 1C). The composition and functional
capabilities of caMediator indicate that we have purified an
intact and active complex.
MultipleTloproteins are expressed and are present in super-
stoichiometric ratios to other caMediator subunits. The mass
spectrometry of purified caMediator indicated the presence of at
least several Tlo proteins, but it did not quantify the stoichiometry
of the Tlo proteins to other subunits or reveal whether Tlo pro-
teins exist in a non-Mediator-associated form. To assess the total
amount of Tlo protein in the cell compared to that of other Me-
diator subunits, we tagged a variety of Tlo and Mediator subunits
with the HA tag. The HA tag was ideal, because the anti-HA anti-
body has no apparent cross-reactivities with native C. albicans
proteins. Since600 bp of sequence 3= of the stop codons of the
Tlo genes has to be eliminated to find differingDNA sequence that
will allow for the specific tagging of a certain TLO, only a subset of
TLO genes was suitable for tagging. We chose Tlo1, Tlo3,
Tlo10, Tlo12, and Tlo34 for our initial round of HA tagging.
As a comparison, we chose two other tail module Mediator sub-
units (Med16 and Med3) and one head module subunit (Med19)
for HA tagging. To analyze the relative expression levels of these
proteins, cells from the tagged strains were grown to mid-log
phase, lysed, and analyzed by Western blotting (Fig. 3). The
amount of total protein loaded was normalized such that an anti-
Tubulin antibody gave an equal amount of signal for all samples
loaded. The Western blot shows that all five Tlo proteins tagged
are expressed and that there is some variability in expression level.
The high expression level for the clade ofTLO genes is consistent
with mRNA measurements (Anderson and Berman, unpub-
lished). The most important observation is that the expression of
individual Tlo proteins either equals or substantially exceeds the
expression of the coreMediator subunits (Fig. 3). If the expression
levels of all of the Tlo proteins are added together, they are present
in vast excess above the levels of the other Mediator subunits.
Since the subunits of S. cerevisiae Mediator are present in a stoi-
chiometric ratio (29), this observation suggested that there is a
large population of non-Mediator-associated Tlo proteins in the
cell. One other notable feature is that HA-tagged Tlo34 protein
runs at a molecular mass close to that of the other Tlo proteins.
The current annotation of the C. albicans genome predicts that
Tlo34 has an extended N terminus (80 amino acids) despite
the existence of a secondATG start codon that alignswith theATG
start codons in the rest of theTLOparalogs. The observedmobility
of Tlo34 does not support the existence of the predicted ex-
tendedN terminus, but it shows that the ATG alignedwith the rest
of the paralogs is the true start codon.
The Tlo proteins are a stoichiometric component of purified
caMediator. To further test the relationship of the Tlo proteins to
FIG 2 Assignment of C. albicansMediator subunits to ORFs and model of its
structure. This figure shows a model of the C. albicans Mediator based on an
updated version of a model of the modular topology of the S. cerevisiaeMedi-
ator (14). We have colored Med5 and Med14 lime green, since they have
characteristics of both tail and middle module subunits. The standardized
Mediator subunit name is followed by the ORF designation in the C. albicans
database in parentheses. The Tlo proteins can serve as orthologs for scMed2.
Elsewhere in the manuscript we discuss the particular Tlo proteins that we
have found can form a subunit of Mediator.
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caMediator, we raised a pan-Tlo polyclonal antibody by immu-
nizing rabbits with two peptides from the N termini of the Tlo
proteins that are 100% identical among all C. albicans paralogs.
Since the mass spectrometry had indicated the presence of at least
several different Tlo proteins in the purifiedMediator, we used the
pan-TLO antibody to determine the total amount of Tlo protein
relative to other Mediator subunits in purified caMediator. The
total amount of Tlo protein in the purified Mediator was cali-
brated using purified recombinant Tlo12, quantified by Brad-
ford assay, as a standard. Analysis of 300 fmol of nativeC. albicans
Mediator by Western blotting with the pan-Tlo antibody gave a
signal that could be quantified by integrating the intensity of the
fluorescent band and comparing it to the intensities of the recom-
binant Tlo12 standards (see Fig. 7B). This process showed that
there is an amount of Tlo protein that is consistent with it being
present in a one-to-one ratio with other subunits in the complex.
This result indicates that theMediator-associated Tlo proteins are
present in roughly equimolar amounts to otherMediator subunits
and is consistent with the Tlo proteins being the structural or-
tholog of scMed2, which is present in a 1:1 stoichiometry with
other members of the S. cerevisiae complex (29).
The multiple bands in the pan-Tlo-N Western blot and the
multiple Tlo proteins identified by mass spectrometry of purified
caMediator support the idea that many different Tlo proteins can
beMediator subunits. To test this hypothesis directly with several
Tlo proteins, we made three strains that each had a 6His-Flag tag
on a different Tlo protein, and we followed the caMediator puri-
fication protocol. Equal amounts of tagged Tlo3, Tlo12, and
Tlo34 were able to pull down an equal amount of Med1 (Fig.
4A), and the composition of the complex pulled down by Tlo3-
6His-Flag and Tlo34-6His-Flag is similar to that of theMediator
pulled down by Med8-6His-Flag as judged by silver staining (Fig.
4B). There is no untagged Tlo band in the complexes pulled down
by Tlo3-6His-Flag and Tlo34-6His-Flag detectable by silver
staining (Fig. 4B) orWestern blotting (data not shown). Combin-
ing these data with those from mass spectrometry, we have direct
evidence that Tlo2, Tlo3, Tlo9, Tlo12, and Tlo34 can asso-
ciate with Mediator. Although we have no additional direct evi-
dence, it is likely that other expressed members of the Tlo family,
such as Tlo1 and Tlo10, can also associate with Mediator. In
total, the data suggest that there are several different populations
of Mediator within a C. albicans cell, each with a unique Tlo pro-
tein component.
Amajority of Tlo protein inC. albicans is in a non-Mediator-
associated form.Our expression data (Fig. 3) suggested that there
is a substantial population of non-Mediator-associated, or free,
Tlo protein in the cell. During our purification of the Tlo-6His-
Flag proteins, we observed that most of the tagged protein was in
the heparin flowthrough (data not shown), while a smaller frac-
FIG3 Expression analysis of Tlo proteins andMediator subunits inwhole-cell
extracts.Whole-cell extracts weremade from strains thatwere untagged or had
a single copy of a Tlo or other Mediator subunit tagged with the HA epitope.
The strain used for each extract is listed in parentheses. (Upper panel) AWest-
ern blot is shown that used an anti-HA antibody for detection. The total
amount of protein loaded in each well was roughly normalized by cell OD,
followed by a precise normalization with an anti-tubulin antibody. (Lower
panel) The blot in this figure was reprobedwith the anti-tubulin antibody, and
each lane was shown to have an equal amount of tubulin. FIG 4 Tlo3, Tlo12, and Tlo34 areMed2 orthologs of caMediator.Whole-
cell lysates from Tlo3-6His-Flag, Tlo12-6His-Flag, and Tlo34-6His-Flag
strains were subjected to our Mediator purification protocol and analyzed by
Western blotting and silver staining. (A) Western blot of various amounts of
protein from the Flag-agarose elutions. One quantity of Tlo12-6His-Flag and
two quantities of Tlo3-6His-Flag and Tlo34-6His-Flag elutions were
loaded. The number in parentheses is the quantity of a sample relative to the
lower quantity. The samples were probed with the caMed1 and Flag antibod-
ies. The ratio of the Flag signal to the caMed1 signal is comparable between all
three samples, indicating that each of the three Tlo proteins in the heparin
elution was able to pull down a proportional amount of intact Mediator. (B)
Comparison of equal amounts of theMed8-6His-Flag, Tlo34-6His-Flag, and
Tlo3-6His-Flag Talon elutions by SDS-PAGE and silver staining of a 10%gel.
The general pattern of silver stain bands indicates that bothTlo34-6His-Flag-
and Tlo3-6His-Flag-purified Mediator are largely identical to the Med8-
6His-Flag pureMediator. Tlo34-6His-Flag and Tlo3-6His-Flag protein ap-
pear to be the only detectable Tlo component of each population of purified
Mediator. The Tlo band observed in the Med8-6His-Flag Mediator is missing
from the Tlo34-6His-Flag and Tlo3-6His-Flag samples, and a new band
appeared at a molecular size that corresponds to the Tlo34-6His-Flag and
Tlo3-6His-Flag signals detected by Western blotting in the corresponding
samples. The molecular mass range occupied by the Tlo band in the Med8-
6His-Flag Mediator is also left absent by the decrease in the molecular size of
Med8, which is untagged in the Tlo-tagged samples.
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tion was in the heparin elution from which we had previously
isolated Mediator. To determine whether the Tlo protein in the
heparin flowthrough was associated with other Mediator sub-
units, we fractionated lysates from a TLO12-Flag strain that had
an HA tag on both copies of Med3. A substantial amount of
Tlo12-Flag protein was unable to bind the resin when the lysate
of the TLO12-Flag cells was applied to heparin Sepharose, as
opposed toMed3-HA,which almost entirely bound to the heparin
(Fig. 5A). When Flag-agarose was used to purify the Tlo12-Flag
protein from the heparin flowthrough and elution, we observed
that the heparin-bound Tlo12-Flag pulled down Med1 and
Med3-HA, while Tlo12-Flag did not (Fig. 5B). This finding is
consistent with earlier expression data (Fig. 3) and indicates that
there is a large cellular population of Tlo protein that is not asso-
ciated with even its closest structural binding partner, Med3, in
theMediator complex. Our estimate for individual Tlo proteins is
that the free form is at least 10-fold more abundant in cells than
the Mediator-associated form.
Since the heparin purification step cleanly separates each Tlo
protein into a Mediator-associated and non-Mediator-associated
form (Fig. 5), the relative amounts of a Tlo protein in the heparin
input and elution are a metric of the affinity of that particular Tlo
protein, versus other Tlo proteins, for Mediator. Although ex-
pressed at different levels, a similar fraction of Tlo12-6His-Flag,
Tlo3-6His-Flag, and Tlo34-6His-Flag protein is bound to hep-
arin (see Fig. S1 in the supplementalmaterial). The similar affinity
of these three Tlo proteins forMediator leads to the conclusion (at
least for Tlo12, Tlo3, and Tlo34) that the population of a
Mediator complex containing a particular Tlo protein will be pro-
portional to the total expression of that Tlo protein.
TheTlo proteins are structurally anchored toMediator com-
plex throughMed3.Work in S. cerevisiae indicates that Mediator
purified fromeither amed2or amed3 strain lacksMed2,Med3,
and Med15 (25, 30), and that recombinant versions of scMed2
and scMed3 expressed in insect cells can form a heterodimer (2).
The connection between Med2 and Med3 in S. cerevisiae extends
in vivo, where the impact ofmed2 ormed3 deletion on global gene
regulation is highly correlated (45). To investigate whether a sim-
ilar relationship between the Tlo proteins and Med3 exists in C.
albicans, we used strategies utilizing both recombinant and native
proteins. First, we made a bicistronic expression vector in which
Tlo12 andMed3 with a C-terminal 6His tag were coexpressed in
E. coli (termed rTlo12). rTlo12 was completely depleted from
cell lysates during purification by IMAC. After IMAC, equimolar
amounts of rTlo12 and rMed3-6His comigrate exactly by both
Mono Q ion-exchange resin (data not shown) and size exclusion
(Fig. 6). Tlo12, and presumably other Tlo proteins, can form a
tight, one-to-one complex with Med3. The cocomplex runs at a
position on size exclusion that is much larger than what would be
expected if one simply adds the molecular sizes of the two pro-
teins. It is unclear whether this results from an unusual shape or
from the oligomerization of the cocomplex.
Our second approach to probe the relationship between the
Tlo proteins andMed3was to purify caMediator from amed3 null
strain and determine whetherMed3was required to retain the Tlo
proteins, and perhaps other subunits, in the native complex. The
med3 null strain is viable and grows with a doubling time similar
to that of the WT at 30°C in YPD. Since Med8 is topologically
distant from proteins likely to be affected by the absence of Med3,
we used a 6His-Flag tag on Med8 to purify the med3Mediator.
The Med8-6His-Flag med3Mediator was purified by following
the same protocol as that for the wild type. In the first step of the
purification, the level of recovery of Med8-6His-Flag signal in the
heparin elution was lower than that of the wild type, indicating
general instability of the complex in themed3/ strain. A largely
intactmed3 complex, however, could be purified from the hep-
arin elution. Using Western blotting to normalize the amount of
Flag andMed1 signal, equimolar amounts ofWT andmed3Me-
diator were analyzed by SDS-PAGE and silver staining (Fig. 7A).
The silver-stained gel shows themed3Mediator to be similar to
wild-typeMediator, asmost bands from thewild type are found in
the mutant. Med5 and Med16, two tail module subunits, are
clearly depleted in the mutant Mediator. Signal in the region for
Med3 and Tlo proteins also appear to be depleted, but it is more
difficult to tell due to the presence of overlapping bands from
FIG 5 Majority of Tlo12 protein is in the heparin unbound protein fraction
and is not associated with Mediator subunits. Lysate from a Tlo12-Flag-
Med3-HA-tagged strain was separated on heparin Sepharose into unbound
and bound fractions. Material from both fractions was purified on Flag-aga-
rose. (A) Western blot analysis (using an anti-Flag and anti-HA antibody) of
the input, flowthrough, and 500 mM KOAc elution (Eltn) of the heparin
column shows that a majority of Med3 binds but that a majority of Tlo12
flows through. The number in parentheses represents the percentage of
1/1,000 of the total amount of each fraction loaded on the gel. (B)Western blot
of the Flag elution from the heparin flowthrough (HepFT/Flag Eltn) and two
amounts of the Flag elution from the heparin elution (Hep500/Flag Eltn)
probed with the caMed1, Flag, and HA antibodies. The Flag signal from the
HepFT/Flag elution sample exceeds that from the Hep500/Flag elution sam-
ples, yet theHepFT/Flag elution contains no detectableMediator asmonitored
by the caMed1 and HA (Med3) antibodies.
FIG 6 Size-exclusion chromatography shows that recombinant C. albicans
Tlo12 and Med3 form a cocomplex. IMAC quantitatively depletes coex-
pressed Tlo12 and Med3-6His from E. coli lysates. The IMAC elution was
separated by ion exchange followed by size exclusion. Input and fractions from
the size-exclusion column (Superose 6) were analyzed by SDS-PAGEon a 12%
gel, followed by staining with Coomassie blue. The relative migrations of two
molecular size standards are marked with respect to the fractions collected.
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other Mediator proteins. Given the structure of the tail module of
scMediator, it seems likely that Med15 is also missing from the
med3Mediator. Since the position of the Med15 band overlaps
that ofMed14 and an impurity, the absence ofMed15 is difficult to
determine by silver stain. The amount of some bands seems to be
enhanced in themed3Mediator. These mostly appear, however,
to be impurities that aremore abundant due to the greater amount
of total protein from the heparin elution that was applied to the
Flag agarose relative to the wild-type sample and the untagged
control. The larger amount was loaded due to the smaller amount
of Flag signal relative to total protein in the med3 heparin elu-
tion. The Cdk8module may be present in a larger fraction of total
Mediator, as those bands stainmore intensely than their wild-type
counterparts. Tomore rigorously assess the presence or absence of
the Tlo proteins in the med3Mediator, we performed Western
blotting with the pan-TLO-N antibody. Using equimolar
amounts of purified wild-type and med3Mediator, normalized
by their Med1 and Flag signals (Fig. 7B), we compared the
amounts of Tlo protein in the two samples. There is no detectable
Tlo protein in the med3 Mediator (Fig. 7B). Our purified
rTlo12/rMed3-6His cocomplex standards show that down to 1/6
of the amount of the Tlo protein in 300 fmol of wild-type Media-
tor can be detected. This puts the lower bound of the depletion at
85% in themed3Mediator. The depletion of Tlo protein does
not seem to be a result of decreased Tlo expression, as tagged
Tlo12 is expressed in comparable amounts in whole-cell extracts
from wild-type andmed3/ strains (data not shown).
Themed3null strain exhibits a defect in germ tubemorphol-
ogy. The primary approach in the molecular genetic analysis of a
new gene is to make a null strain. The challenge to taking this
approach with the C. albicans TLO genes is the daunting task of
deleting both copies of all 14 TLO paralogs to make a clean null
mutant. Our data presented here and previous results for S. cerevi-
siae suggest that Med2 and Med3 work together through Media-
tor. Although it is likely that caMED3 has functions that are inde-
pendent of theTLO genes, we hypothesize that many of the effects
of caMed3 deletion on Mediator function are similar to the effect
of TLO deletion on Mediator function. Hence, we have begun to
characterize the phenotype of the med3 null mutant. To perform
this analysis, we have created several independently derivedmed3
null strains, a complementedmed3 null in whichMED3-ARG4 is
introduced at the native MED3 locus, and a complementation
control inwhichARG4 is introduced at the nativeMED3 locus. All
strains were viable and grewwith similar doubling times in YPD at
30°C and at 37°C degrees, and they had similarmorphology under
these conditions (data not shown). The analysis of a C. dublinien-
sis TLO1 (cdTLO1) null mutant indicated that there was a defect
in hyphal formation that could be complemented by the C. albi-
cans TLO11 and TLO12 genes, as well as the C. dubliniensis
TLO1 gene (20). Hence, we sought to determine the extent to
which MED3 is required for hyphal filament formation in liquid
medium under GlcNAc- and temperature-induced conditions.
We performed GlcNAc and temperature induction time-course
experiments in which cells fromwild-type,med3/, and various
control strains were harvested after 1, 2.5, and 3.5 h and examined
by Nomarski/DIC and fluorescence microscopy after staining
with Blankophor (see Fig. S2 in the supplemental material). In
contrast to the wild type, the med3/ mutant exhibited a clear
defect in hyphal filament morphology. Filaments formed in the
med3/mutant by 2.5 h; however, they aremuch shorter and do
not share similarmorphologywith cells that have awild-type copy
of MED3 (Fig. 8). In the med3/ strain, staining chitin with
Blankophor (16) showed that a septal ring remained at the point
of emergence of the filament from the blastospore and at points of
constriction along the filament. In the strains with a wild-type
copy ofMED3, the filaments are longer and have properties typi-
cally associatedwith germ tubes, such as parallel cell walls inwhich
the first septum forms within the germ tube (42). The GlcNAc-
and temperature-induced filaments in themed3/ strain exhibit
many hallmarks consistent with their classification as pseudohy-
phae (42). Using serum and temperature to induce filamentation,
FIG 7 caMediator purified from a med3 null strain lacks Tlo proteins and
other tail module subunits. (A) Lysate from an untagged, Med8-6His-Flag-
tagged WT strain and a Med8-6His-Flag-tagged med3 null strain were sub-
jected, in parallel, tomultiple chromatographic separations. The elutions from
the IMAC (Talon) step were analyzed by 7.5% (results above the asterisk) and
12.5% (below the asterisk) SDS-PAGE. The two gels were run on identical
samples to ensure adequate resolution in both the high- and low-molecular-
mass ranges. Proteins were revealed by staining with silver. The positions of
bands identified in Fig. 1, which differ in themed3Mediator, aremarkedwith
arrows. (B) Western blotting comparing various amounts of purifiedWT and
med3Mediator and recombinant Tlo12/Med3-6His complex. The amount
ofWTMediator was estimated by comparison of band intensity on a Coomas-
sie gel to a known standard (data not shown). caMed1 and Flag antibodies
were used to demonstrate a normalized amount ofMed1, andMed8-6His-Flag
was present in both the purified WT and med3 Mediator. The pan-Tlo-N
antibody was used to detect Tlo proteins in normalized amounts of the WT
and med3 Mediator. The sensitivity of the pan-Tlo-N antibody was cali-
brated by adding known amounts of our recombinant Tlo12/Med3-6His
complex. These standards show that the amount of Tlo protein in the WT
Mediator is roughly equimolar to the total amount of Mediator loaded, and
that the depletion of Tlo protein in the med3 Mediator at least exceeds
85%.
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or performing the analysis in an MTLa/ strain background, re-
sulted in identical phenotype differences between the wild type
andmed3mutant (data not shown).
DISCUSSION
This study reports the first biochemical characterization of Medi-
ator from C. albicans. Our analysis has revealed that the composi-
tion of the complex is identical to that of its S. cerevisiae counter-
part, with no additional subunits, providing a sound basis for
extending the findings for S. cerevisiae to C. albicans. Given the
central role of Mediator in transcriptional regulation, this meth-
odology provides a new vehicle for precise parallel biochemical
and molecular genetic studies of caMediator in the complex reg-
ulatory patterns that underlie C. albicans virulence. A recent ge-
netic analysis of the highly conserved MED20, MED31, and
MED13 genes in C. albicans showed that caMediator has roles in
the expression of genes associated with virulence, such as genes
related tomorphogenesis and gene families enriched in pathogens
(44). The purification of the Cdk8 module with caMediator pro-
vides opportunities for more directed studies of the components
of this module that are frequently being identified as critical play-
ers in signaling pathways associated with virulence in fungal
pathogens.med13 null mutants have been reported to exhibit in-
creased filamentous growth and abnormal cell wall morphology
(46), andMed12 null mutants exhibit abnormal colony morphol-
ogy (33). Although the subunit composition of caMediator and
scMediator is similar, the subunits and modules may functionally
participate in completely different pathways and be part of the
large-scale rewiring of transcriptional networks that has been
demonstrated for DNA-bound transcription factors inC. albicans
(4). Our discovery that the Tlo proteins are subunits of Mediator
and the structural ortholog of scMed2 provides the greatest point
of departure between caMediator and Mediator in other species,
fungal or otherwise.
The combination of the direct interaction between Tlo12 and
Med3, the finding that Tlo proteins are anchored within the tail
module of Mediator through Med3, and the previously observed
distant sequence similarity between scMed2 and the Tlo proteins
(6) all point to the Tlo proteins being the true structural C. albi-
cans orthologs of scMed2. In S. cerevisiae, Med2, Med3, and
Med15 form a trimeric complex within the tail module (3). Me-
diator purified from either a med2, med3, or med15 S. cerevi-
siae strain lacks these three subunits but is otherwise intact (25,
30).Med3, and presumably the Tlo proteins, plays an even greater
role in C. albicans tail module stability, as our work shows that
Med5 andMed16 are alsomissing from themed3Mediator. The
stability of purified protein complexes, however, can differ from
their stability in vivo. This leaves open the possibility that a more
intact tail module exists in med3 null cells. Although other tail
module subunits, such as Med15 and Med16, are well conserved
in S. cerevisiae and C. albicans, the sequences for Tlo/Med2 and
Med3 have diverged substantially between the two fungi. This
divergence is reflected in the finding that Tlo12 is unable to
complement a med2 gal phenotype in S. cerevisiae (data not
shown). The functional role of Tlo/Med2 and Med3 in the tail
module of Mediator may be fungus specific. Among metazoan
Mediator subunits, there are two that have been proposed to be
distant scMed2 and scMed3 sequence-based orthologs. These
subunits, however, have been characterized as head rather than
tail module subunits and may play a decidedly different functional/
structural role than their proposed fungal counterparts (6).
We have found that at least 5 of the 14 C. albicans Tlo paralogs
can be incorporated into the caMediator complex. These individ-
ual Tlo subunits are present in a percentage of Mediator com-
plexes in the cell that appears to be proportional to their expres-
sion, with no detectable sequence preference. Our data also
suggest that there are several different Mediator complexes in C.
albicans cells, each differing only in the identity of their Tlo pro-
tein subunit. Although we only have definitive data for 5 Tlo pro-
teins, it is expected that all expressed Tlo proteins can associate
withMediator. The expression of multiple Tlo paralogs is striking
compared to all otherMediator subunits in C. albicans and, to the
best of our knowledge, all Mediator subunits in virtually all eu-
karyotes which are only present as a single ortholog. Although C.
dubliniensis has two genomic Tlo paralogs (TLO1 and TLO2), it
appears that the expression of only one is detectable (L. C. Myers,
unpublished data). A second striking difference between the TLO
genes and genes encoding other Mediator subunits, within C. al-
bicans and otherwise, is their varying levels of expression under
different conditions (11, 48). This, of course, begs the question as
to what advantage the expression of multiple paralogs confers
upon C. albicans that has resulted in the maintenance of the TLO
family throughout evolution. The two most straightforward rea-
FIG 8 Morphology of MED3/ (yLM93), med3/ (yLM96), and med3/
plus MED3-ARG4 (AZC53-3) cells undergoing the blastospore-to-filament
transition. All strains were grown under non-filament-inducing conditions
and were diluted into prewarmed YPDmedium at 37°C in the presence of 2.5
mM GlcNAc. Cells were removed at various time points and stained with
Blankophor. Each panel shows a separate strain after 2.5 h of induction. Ar-
rows point to the location of septa formed along the filament. A complete set of
strains from an entire time course is shown in Fig. S2 in the supplemental
material. Bar at bottom left, 10 m.
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sons are to provide some necessary functional variation that could
arise from the sequence variation and to simply make more pro-
tein. Since there does not appear to be any sequence discrimina-
tion between Tlo proteins in regard to Mediator binding, se-
quence variation could affect Mediator interactions with other
proteins. Alternatively, the primary function of the multiple Tlo
paralogs could be to producemore protein.Wehave observed that
there is Tlo protein in excess of what is required for Mediator.
When epitope tagging is used to quantitate protein expression,
there is the possibility that the tag or the removal of the native
3=-UTR could affect expression.We do not believe tagging is caus-
ing the observed Tlo abundance, since we find that the tagged Tlo
proteins only pull down a small fraction of the total Tlo-contain-
ing Mediator in the cell. It unlikely that large amounts of Tlo
proteins are necessary to drive their association with Mediator,
since our data show that the Tlo proteins are tightly associated
with the rest of the Mediator complex and copurify over several
chromatographic steps. Another possibility is that excess Tlo pro-
tein is important for some additional function besides its direct
association with Mediator. The primary function of the Med2/
Med3/Med15 submodule in S. cerevisiae appears to be transcrip-
tional activation. med2, med3, and med15Mediator mutants
in S. cerevisiae lose their ability to respond to a number of tran-
scriptional activators in vivo and in purified transcription systems
(3). Within this trimeric complex, Med15 appears to be the pri-
mary direct target of interactions with activation domains (7);
however, one could envision a role of excess Tlo protein in atten-
uating the ability of the tail module to respond to activation by a
squelching mechanism.
The complex transcriptional program that underlies hypha
formation inC. albicans can respond to varied signals and involves
many different sequence-specific DNA-bound transcription fac-
tors (41). A considerable amount is known about these sequence-
specific DNA-bound transcription factors, but much less is
known about their downstream targets. Recently, chromatin
modification and remodeling has been revealed to play an impor-
tant role in facilitating the action of these DNA-bound transcrip-
tion factors (26, 27), but this is certainly only one aspect of a
complex mechanism. Given the well-established role of Mediator
in facilitating the regulation of specific gene expression programs,
the demonstration that caMed3 and the Tlo proteins influence
hyphal morphology suggests that these subunits work directly
with DNA-bound factors to regulate genes involved in the yeast-
to-hypha transition. This hypothesis will need to be tested in fu-
ture work. Among all of the coactivators and corepressors that
may influence the hyphal transcriptional program, caMed3 and
the Tlo proteins are particularly intriguing due to their fungus-
and C. albicans-specific properties that would differentiate the
pathogens from the human host.
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